Ameriprise Financial Inc Iovance Biotherapeutics, Inc. Transaction History

Ameriprise Financial Inc

  • $381 Billion
  • Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 557,534 shares of IOVA stock, worth $4.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
557,534
Previous 27,999 1891.26%
Holding current value
$4.54 Million
Previous $224,000 2237.05%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$7.28 - $11.9 $3.86 Million - $6.3 Million
529,535 Added 1891.26%
557,534 $5.24 Million
Q2 2024

Aug 14, 2024
SELL
$7.78 - $14.19 $186,696 - $340,517
-23,997 Reduced 46.15%
27,999 $224,000
Q1 2024

May 15, 2024
BUY
$7.59 - $17.47 $185,772 - $427,595
24,476 Added 88.94%
51,996 $770,000
Q4 2023

Feb 14, 2024
BUY
$3.3 - $8.89 $3,580 - $9,645
1,085 Added 4.1%
27,520 $223,000
Q3 2023

Nov 14, 2023
BUY
$4.44 - $8.79 $117,371 - $232,363
26,435 New
26,435 $120,000
Q1 2023

May 15, 2023
SELL
$5.53 - $8.22 $6.46 Million - $9.6 Million
-1,168,247 Reduced 89.09%
143,013 $873,000
Q4 2022

Feb 14, 2023
SELL
$5.62 - $10.0 $6.75 Million - $12 Million
-1,200,907 Reduced 47.8%
1,311,260 $8.38 Million
Q3 2022

Nov 14, 2022
SELL
$9.53 - $13.11 $4.74 Million - $6.53 Million
-497,847 Reduced 16.54%
2,512,167 $24.1 Million
Q2 2022

Aug 15, 2022
BUY
$6.38 - $18.33 $3.12 Million - $8.95 Million
488,509 Added 19.37%
3,010,014 $33.2 Million
Q1 2022

May 16, 2022
BUY
$12.38 - $19.1 $641,234 - $989,303
51,796 Added 2.1%
2,521,505 $42 Million
Q4 2021

Feb 14, 2022
BUY
$16.55 - $27.63 $4.93 Million - $8.24 Million
298,109 Added 13.73%
2,469,709 $47.2 Million
Q3 2021

Nov 15, 2021
BUY
$20.35 - $26.63 $18 Million - $23.6 Million
885,153 Added 68.81%
2,171,600 $53.6 Million
Q2 2021

Aug 16, 2021
BUY
$16.33 - $33.07 $13.6 Million - $27.5 Million
832,124 Added 183.16%
1,286,447 $33.5 Million
Q1 2021

May 17, 2021
BUY
$28.67 - $52.59 $3.35 Million - $6.14 Million
116,815 Added 34.61%
454,323 $14.4 Million
Q4 2020

Feb 12, 2021
BUY
$28.04 - $50.26 $2.58 Million - $4.62 Million
91,843 Added 37.39%
337,508 $15.7 Million
Q3 2020

Nov 16, 2020
BUY
$27.75 - $36.3 $6.52 Million - $8.52 Million
234,775 Added 2155.88%
245,665 $8.09 Million
Q2 2020

Aug 14, 2020
BUY
$27.21 - $41.0 $49,250 - $74,210
1,810 Added 19.93%
10,890 $292,000
Q1 2020

May 15, 2020
BUY
$19.54 - $38.85 $177,423 - $352,758
9,080 New
9,080 $225,000
Q2 2018

Aug 14, 2018
SELL
$12.45 - $16.95 $886,452 - $1.21 Million
-71,201 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$8.1 - $19.5 $576,728 - $1.39 Million
71,201 New
71,201 $1.2 Million

Others Institutions Holding IOVA

# of Institutions
313
Shares Held
241M
Call Options Held
3.77M
Put Options Held
1.7M
View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

IOVA Quotes by TradingView
  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.28B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email